Literature DB >> 23022161

Aggressive posterior retinopathy of prematurity: risk factors for retinal detachment despite confluent laser photocoagulation.

Gaurav Sanghi1, Mangat R Dogra, Deeksha Katoch, Amod Gupta.   

Abstract

PURPOSE: To analyze risk factors for retinal detachment in eyes with aggressive posterior retinopathy of prematurity (ROP) treated with confluent laser photocoagulation.
DESIGN: Retrospective, consecutive, interventional case series.
METHODS: Infants undergoing laser treatment for aggressive posterior ROP from January 2006 through June 2010 participated. Eyes with retinal detachment (stage 4A, 4B, and 5) at presentation and those lost to follow-up after treatments were excluded. We defined 2 groups based on outcome after confluent laser photocoagulation: retinal detachment or favorable outcome. Two groups were compared for various factors, which included birth weight, gestational age, postconceptional age at laser treatment, zone of disease, preretinal hemorrhage, pre-existing fibrovascular proliferation, tunica vasculosa lentis, laser spots used for primary treatment, need for repeat laser treatment, and new-onset fibrovascular proliferation after laser treatment. Data were analyzed using univariate and multivariate logistic regression analysis.
RESULTS: One hundred nineteen eyes of 61 infants underwent laser treatment for aggressive posterior ROP. Ten (8.4%) eyes were excluded and 109 eyes (91.6%) were included. Nineteen (17.4%) of 109 eyes progressed to retinal detachment after laser treatment. On univariate analysis, multiple factors were associated with retinal detachment. Of these, all eyes with posterior zone 1 disease and all eyes demonstrating extensive fibrovascular proliferation (> 3 clock hours) after laser treatment progressed to retinal detachment. On multivariate logistic regression analysis, the most significant predictors of retinal detachment were gestational age of less than 29.5 weeks (P = .006), hemorrhages (P = .003), need for repeat laser treatment (P = .006), and new-onset limited fibrovascular traction (< 3 clock hours) after laser treatment (P = .042).
CONCLUSIONS: A gestational age of less than 29.5 weeks, posterior zone 1 disease, and preretinal hemorrhages before laser treatment are the most significant risk factors for retinal detachment in aggressive posterior ROP. Of the events occurring after laser treatment, new-onset fibrovascular traction is associated significantly with development of retinal detachment.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23022161     DOI: 10.1016/j.ajo.2012.07.012

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  26 in total

1.  One-year clinical outcome after laser treatment for retinopathy of prematurity at a tertiary center in Turkey.

Authors:  Murat Gunay; Gokhan Celik; Fahri Ovali; Huseyin Yetik; Alev Aktas; Betul Onal Gunay
Journal:  Int Ophthalmol       Date:  2014-11-09       Impact factor: 2.031

2.  Outcomes after Intravitreal Bevacizumab versus Laser Photocoagulation for Retinopathy of Prematurity: A 5-Year Retrospective Analysis.

Authors:  Christopher K Hwang; G Baker Hubbard; Amy K Hutchinson; Scott R Lambert
Journal:  Ophthalmology       Date:  2015-02-14       Impact factor: 12.079

3.  Low-dose ranibizumab administration in retinopathy of prematurity.

Authors:  Levent Tök; Lütfi Seyrek; Özlem Yalçın Tök
Journal:  Int Ophthalmol       Date:  2022-01-07       Impact factor: 2.031

4.  Aggressive Posterior Retinopathy of Prematurity (APROP): LASER as the Primary Modality of Treatment.

Authors:  Shilpi H Narnaware; Prashant K Bawankule; Dhananjay Raje
Journal:  J Ophthalmic Vis Res       Date:  2021-07-29

5.  Ocular complications following treatment in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study.

Authors:  David Morrison; James Shaffer; Gui-Shuang Ying; Gil Binenbaum
Journal:  J AAPOS       Date:  2018-03-14       Impact factor: 1.220

6.  Effect of two different doses of intravitreal bevacizumab with temporal retina-sparing laser photocoagulation for retinopathy of prematurity.

Authors:  A Young Choi; Hochan Cho; Yu Cheol Kim
Journal:  Int J Ophthalmol       Date:  2018-01-18       Impact factor: 1.779

Review 7.  An Update on Retinopathy of Prematurity (ROP).

Authors:  Mangat Ram Dogra; Deeksha Katoch; Mohit Dogra
Journal:  Indian J Pediatr       Date:  2017-07-04       Impact factor: 1.967

Review 8.  Retinopathy of prematurity treatment: Asian perspectives.

Authors:  Parveen Sen; Wei-Chi Wu; Parijat Chandra; Anand Vinekar; Pradeep T Manchegowda; Pramod Bhende
Journal:  Eye (Lond)       Date:  2019-10-29       Impact factor: 3.775

Review 9.  Aggressive posterior retinopathy of prematurity: a review on current understanding.

Authors:  Devesh Kumawat; Anusha Sachan; Pooja Shah; Rohan Chawla; Parijat Chandra
Journal:  Eye (Lond)       Date:  2021-01-29       Impact factor: 3.775

10.  Treatment for retinopathy of prematurity in an infant with adenoviral conjunctivitis.

Authors:  Murat Gunay; Gokhan Celik; Rahim Con
Journal:  Case Rep Pediatr       Date:  2015-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.